Galera Therapeutics

IPO

Transforming the science and treatment of cancer.

Public · Malvern · Founded 2009 · $203.9M raised

Headquarters
Malvern
Employees
1–10
Founded
2009
Business Model
B2B
Total Funding
$203.9M
Last Round
$869K GrantSep 2020
Rounds
4
Type
Public

About

Galera Therapeutics is a clinical-stage biopharmaceutical company pioneering novel small molecules that target critical vulnerabilities in cancer cells, immune cells, and the tumor microenvironment. Based in Malvern, Pennsylvania, Galera focuses on improving the anti-cancer efficacy of current therapies, particularly for patients with breast cancer.

Summary

Galera Therapeutics is a Biotech company based in Malvern, founded in 2009. It has raised $203.9M in total across 4 rounds, most recently a $869K Grant round in Sep 2020. Investors include New Enterprise Associates, Novartis Venture Fund and Novo Holdings A/S.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Sep 2020
$869K

Sign up to see all 5 rounds

Series A through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Galera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/galera-therapeutics"><img src="https://indexed.vc/api/badge/company/galera-therapeutics" alt="Galera Therapeutics on Indexed.vc" width="260" height="76" /></a>